Lacerta Therapeutics

Developer of adeno-associated virus for CNS diseases

placeAlachua, Florida, United States calendar_todayFounded 2015 groups43 employees language lacertatx.com

Registered entities

Innovation

3 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 24 times.

YearFilings
20211
20221
20231
20242

Investor mix

3 investors on record; lead investors include Sarepta, National Cancer Institute.

Investor typeCountShare
Other / undisclosed3100%
Coming soon